The disruption of the negative feedback on gp130-dependent STAT signaling causes STAT3 hyperactivation, and these mice develop a broad spectrum of hematopoietic abnormalities, including splenomegaly, lymphadenopathy, thrombocytosis and autoimmune arthritis [51-54]. This evidence concerns the gene SOAT1 and thrombocytosis disease.